Rabdosia rubescens Linn: green synthesis of gold nanoparticles and their anticancer effects against human lung cancer cells A549
Source abstract
Abstract
(RR-AuNP) and analyzed its anticancer activity against the lung carcinoma A549 cell lines. Since lung cancer is reported to be with increased morbidity and decreased survival rate. The biosynthesized RR-AuNP were confirmed using UV-Visible spectrophotometer, size and shape of RR-AuNP were assessed by DLS, TEM and EDX. The biomolecules present in RR-AuNP and its topographical structure were detected using FTIR, SAED and AFM analysis. MTT assay was performed to detect the IC50 dose of RR-AuNP and its apoptotic effect was assessed by detecting the caspases activation, ROS generation. The anticancer effect of RR-AuNP was confirmed by DAPI staining, TUNEL assay and its molecular mechanism were confirmed by assessing the apoptotic signalling molecules protein expression. Our results illustrate that RR-AuNP showed a strong absorption peak at 550 nm and the RRAuNP were polydispersed nanospheres with size of 130 nm. RR-AuNP IC50 dose against A549 lung carcinoma cell line was detected to be at 25 µg/ml. The results of DAPI staining, TUNEL and immunoblotting analysis confirms both the 25 µg/ml and 50 µg/ml of RR-AuNP possess potent anticancer and apoptotic effect, suggesting that RR-AuNP that it may be a persuasive molecule to treat lung cancer.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Urban Development and Societal Issues
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Thoracic Surgery, Shaanxi Provincial Tumor Hospital
Department of Pulmonary Disease, Jinan Municipal Hospital of Traditional Chinese Medicine
Innoscience Research Sdn Bhd
References (38)
Show source-provided references
1. 10.1007/s11356-017-9789-410.1007/s11356-017-9789-4 ↗
2. 10.1007/s00204-012-1007-z10.1007/s00204-012-1007-z ↗
3. 10.1166/jnn.2014.901910.1166/jnn.2014.9019 ↗
4. 10.1021/bp050142310.1021/bp0501423 ↗
5. 10.1016/j.colsurfb.2010.07.03610.1016/j.colsurfb.2010.07.036 ↗
6. 10.1016/j.bios.2011.06.01710.1016/j.bios.2011.06.017 ↗
7. 10.1016/j.nano.2007.11.00410.1016/j.nano.2007.11.004 ↗
8. 10.1166/jnn.2011.472610.1166/jnn.2011.4726 ↗
9. 10.1016/j.saa.2010.10.01510.1016/j.saa.2010.10.015 ↗
10. 10.1056/NEJM19980917339120110.1056/NEJM199809173391201 ↗
11. 10.1038/nm0195-2710.1038/nm0195-27 ↗
12. National Pharmacopoeia Committee. Pharmacopoeia of People's Republic of China 2015. Beijing, China: National Pharmacopoeia Committee; 2015.
13. 10.1016/j.chroma.2013.07.03910.1016/j.chroma.2013.07.039 ↗
14. Takeda Y, Otsuka H. Recent advances in the chemistry of diterpenoids from Rabdosia species. Stud Nat Prod Chem. 1995;15:111e85.
15. Liu C, Zhao Z. Advances in research of Rabdosia rubescens (Hemsl.) Hara. Chin Pharm J. 1998;33:577e81.
16. Sun HD, Lin ZW, Qin CQ, et al. Studies on the chemical constituents of antitumor plant Rabdosia rubescens (Hemsl.) Hara. Acta Bot Yunn. 1981;3:95e100.
17. National Cancer Institute. SEER Cancer Statistics Review 1975–2011. Available online: http://seer.cancer.gov/csr/1975_2011/
18. National Cancer Center; 2017. National Cancer Registry Programme. Three Year Report of Population Based Cancer Registries: 2014–2017.
19. 10.1093/jnci/djr32510.1093/jnci/djr325 ↗
20. 10.1186/s13014-018-0981-610.1186/s13014-018-0981-6 ↗
21. 10.1158/1535-7163.MCT-06-014110.1158/1535-7163.MCT-06-0141 ↗
22. 10.1039/C3RA45345F10.1039/C3RA45345F ↗
23. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
24. 10.1200/JCO.1989.7.8.108710.1200/JCO.1989.7.8.1087 ↗
25. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
26. 10.1007/s10853-008-2745-410.1007/s10853-008-2745-4 ↗
27. 10.1016/j.colsurfb.2009.08.02810.1016/j.colsurfb.2009.08.028 ↗
28. Ali DM, Sasikala M, Gunasekaran M, et al. Biosynthesis and characterization of silver nanoparticles using marine Cyanobacterium, Oscillatoria willei NTDM01. Digest J Nanomater Biostruct. 2011;6:385–390.
29. 10.1248/bpb.17.63510.1248/bpb.17.635 ↗
30. Blagoi YP Galkin VL Gladchenko GO et al. Metal complexes of nucleic acids in solutions. Naukova Dymka Kiev (in Russian). 1991. p. 272.
31. 10.2147/IJN.S783310.2147/IJN.S7833 ↗
32. 10.1038/sj.cdd.440172410.1038/sj.cdd.4401724 ↗
33. Vaux D, Silke J. Mammalian mitochondrial IAP-binding proteins. Biochem Biophy Res Commun. 2003;203:449–504.
34. Kumar V, Abbas AK, Fausto N, et al. Robins and Cotran: pathologic basis of disease. 8th ed. Philadelphia: Saunders Elsevier; 2010, p. 25–32
35. 10.1111/j.1476-4431.2008.00363.x10.1111/j.1476-4431.2008.00363.x ↗
36. Karp G. Cell and molecular biology: concepts and experiments. 5th ed. New Jersey: John Wiley and Sons; 2008, p. 653–657.
37. Reed JC. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in haematologic malignancies. Semin Haematol. 1997;34:9–19.
38. 10.1038/cdd.2010.19110.1038/cdd.2010.191 ↗